Sponsor or institution

Clinical trials and research at Jiangsu vcare pharmaceutical technology co., LTD

• 9Clinical trials
• 1Country

Newest trials

All recruiting trials (9)

• VC005 tablets in teens with severe alopecia areata

  This Phase 1 study tests VC005 tablets in adolescents with severe alopecia areata to see how the drug behaves in the body, whether it is safe, and if there are signs of benefit.

  Recruiting Phase 1 Jiangsu vcare pharmaceutical technology co., LTD · Beijing, Beijing Municipality · NCT07762443

• VC005 tablets in severe alopecia areata

  This study tests whether VC005 tablets work better than a placebo for adults with severe alopecia areata.

  Recruiting Phase 2 Jiangsu vcare pharmaceutical technology co., LTD · Beijing, Beijing Municipality · NCT07749716

• VC005 gel in adults with mild to moderate atopic dermatitis

  This study tests whether VC005 gel works better than a placebo gel for adults with mild to moderate atopic dermatitis.

  Recruiting Phase 2 Jiangsu vcare pharmaceutical technology co., LTD · Hangzhou, Zhejiang · NCT07598383

• VC005 for adults and teens with mild to moderate atopic dermatitis

  This study tests VC005 versus placebo to see if it helps people 12 and older with mild to moderate atopic dermatitis.

  Recruiting Phase 3 Jiangsu vcare pharmaceutical technology co., LTD · Nanjing, Jiangsu · NCT07592585

• VC005 tablets for adults with active ankylosing spondylitis

  This Phase III trial will test whether VC005 tablets are safe and help reduce symptoms in adults with active ankylosing spondylitis.

  Recruiting Phase 3 Jiangsu vcare pharmaceutical technology co., LTD · Beijing, Beijing Municipality · NCT07172360

• VC005 tablets for people with non-segmental vitiligo

  This trial will test VC005 tablets to see if they safely help adults aged 18–70 with non-segmental vitiligo regain skin pigment.

  Recruiting Phase 2 Jiangsu vcare pharmaceutical technology co., LTD · Beijing, Beijng · NCT07172347

• Testing VC005 tablets for adults with moderate to severe atopic dermatitis

  This study is testing if VC005 tablets can help adults with moderate to severe eczema feel better and improve their quality of life.

  Recruiting Phase 3 Jiangsu vcare pharmaceutical technology co., LTD · Nanjing, Jiangsu · NCT06723080

• Evaluating VC004 for patients with advanced solid tumors

  This study is testing a new medication called VC004 to see if it helps people with advanced solid tumors feel better and manage their condition.

  Recruiting Phase 3 Jiangsu vcare pharmaceutical technology co., LTD · Beijing, Beijing Municipality · NCT06658353

• Evaluating Vicagrel for patients with Acute Coronary Syndrome undergoing heart procedures

  This study is testing if a new medication called Vicagrel can help people with Acute Coronary Syndrome who are having heart procedures feel better and stay safe compared to a standard treatment.

  Recruiting Phase 3 Jiangsu vcare pharmaceutical technology co., LTD · Shenyang, Liaoning · NCT06577519

Quick answers

How many clinical trials run by Jiangsu vcare pharmaceutical technology co., LTD are recruiting right now?

9, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in China. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 3: 5, Phase 2: 3, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →